Bivalirudin and dialysis
WebA study comparing the pharmacokinetics and pharmacodynamics of bivalirudin with normal renal function (GFR greater than or = 90 ml/minute; n = 8), mild (GFR 60-89 ml/minute; n = 8), moderate (GFR 30-59 ml/minute; n = 7), or severe (GFR < 30 ml/minute; n = 10) renal impairment showed that while clearance was similar in the normal (4.58 … WebNov 16, 2005 · Bivalirudin was initiated by continuous intravenous infusion (range 0.03–0.2 mg/kg/h) and adjusted to an aPTT of 1.5–2.5 times patient baseline. The mean infusion rate was 0.1 mg/kg/h. The average duration of therapy was 7.8 (range 1–24) days. 7/42 (16.7%) of patients had overt bleeding and received ≥ 2 units of packed red blood cells ...
Bivalirudin and dialysis
Did you know?
WebSep 1, 2011 · An initial dose of bivalirudin 0.15-0.2 mg/kg/h, adjusted to an activated partial thromboplastin time (aPTT) of 1.5-2.5 times the baseline value, has been suggested. Initial dosing in patients... WebTraductions en contexte de "impaired renal function Doxorubicin" en anglais-français avec Reverso Context : Use in patients with impaired renal function Doxorubicin is metabolised largely by the liver and excreted in the bile.
WebThe disposition of bivalirudin was studied in PTCA patients with mild and moderate renal function and in patients with severe renal function. Drug elimination was related to glomerular filtration rate (GFR). Total body clearance was similar for patients with normal renal function and with mild renal impairment (60-89mL/min). Clearance WebAug 31, 2011 · To evaluate initial bivalirudin dosing requirements in patients with and without renal dysfunction, including patients on different forms of dialysis. Methods: A …
WebJul 9, 2024 · “Bilvairudin has tremendous potential to supplant heparin for several reasons: It binds directly to thrombin, causing more predictable pharmacokinetics and eliminating the need for supplementing low antithrombin levels; it inhibits both circulating and clot-bound thrombin; and it is not associated with heparin-induced thrombocytopenia (HIT),” … WebThe median initial bivalirudin dose to achieve target activated partial thromboplastin time was 0.15 mg/kg/h (range 0.04–0.26 mg/kg/h). Dosing requirements increased by 75–125% when renal replacement was included. Median time on …
WebSep 11, 2024 · Bivalirudin, a direct thrombin blocker, may represent an effective alternative for patients suffering from heparin-induced thrombocytopenia (HIT). We present the first case of a Chinese patient who experienced HIT and received bivalirudin anticoagulation during ECMO. In addition, we present a systematic review for this topic.
WebApr 11, 2024 · In the United States, about one million people are seen to visit the operating theater for cardiac surgery annually. However, nearly half of these visits result in complications such as renal, neurological, and cardiac injury of varying degrees. Historically, many mechanisms and approaches have been explored in attempts to reduce injuries … shyam poudel google scholarWebSep 15, 2024 · Bivalirudin is a prescription medicine used to treat the symptoms of Percutaneous Coronary Intervention. Bivalirudin may be used alone or with other medications. Bivalirudin belongs to a class of drugs called Anticoagulants, Cardiovascular; Anticoagulants, Hematologic. It is not known if Bivalirudin is safe and effective in children. shyam posterWebJan 12, 2024 · Bivalirudin does not bind to plasma proteins (other than thrombin) or to red blood cells. Elimination. Bivalirudin has a half-life of 25 minutes in PTCA patients with normal renal function. The total body … shyam ragireddy vs microinfoWebJan 15, 2016 · Additionally, there were non-significant trends towards high use of warfarin in patients treated with bivalirudin. Data from the BRAVO study demonstrated that … shyam plasticWebUFH Enoxaparin Fondaparinux Bivalirudin Eptifibatide Abciximab Tirofiban . Mechanism & Duration . Thrombin and factor Xa inactivation. Prevents conversion of fibrinogen to fibrin . Duration: 1 - 2 hrs ... is on dialysis; CrCl<50ml/min: Clearance reduced by 50% None CrCl ≤60 mL/min: Decrease post loading dose infusion by 50% to 0.075 mcg/kg ... shyam prayaas foundationWebOct 23, 2024 · Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia. Ann Pharmacother . 2011;45(10):1185–1192. shyam plastic industriesWebDec 15, 2024 · In dialysis-dependent patients, reduce off-dialysis infusion rate to 0.25 mg/kg per hour. Hepatic Impairment No specific dosage recommendations. Geriatric Patients No specific dosage recommendations. Detailed Bivalirudin dosage information Cautions for Bivalirudin Contraindications Active major bleeding. the pathwork lectures